Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: William Strop who wrote (463)	1/6/1998 11:14:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 1972

William - several factors could do it. (BTW, I looked at several biotech charts today that had large 97 sell offs, and a majority show signs of turning around - way too soon to declare a trend tho) A couple "market gurus"/newsletter writers, significant positive news from several biotechs (Phase IIIs, FDA approvals, more alliances & large milestone payments. etc. could make an undervalued sector hot, especially if the news is good enough to cause short covering. Case in point. May 96 Worth featured ISIP & VICL as potential "Next Microsofts". Feb issue came out over weekend with Update on ISIP (did anyone see it, any comments on VICL? - new issue has not hit streats here yet) Anyway, ISIP went bonkers, this afternoon probably had some short covering. So anyway, I'm increasing my scrutany of this sector to try & spot a sector trend. Scott

To: William Strop who wrote (463)	1/7/1998 5:33:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 1972

OK William, your on. Since you essentially solicited my purchasing VICL, does that make u responsible if I lose my very modest stake? Scott. Woody Allan once remarked "I refuse to join any club that would have me as a member", or something to that effect. Since my biggest holding is losing ground despite great EPS growth (-.72 .06 .15 .27 .45 last 5 qtrs) and Great balance sheet ratios (Profit margin 13.2, P/Sales 1.14, P/Cash Flow 6.3, ROE 53.2, ROA 36.7, Debt/Equity 0.00), and my most casual pick, UNRG has been a 7+ bagger for me, the fact that I have been considering VICL for months & reading what I can may not be a pretty omen for ya'll. So I need to ask, r u sur u want 2 hav me on this thread?